Prevalence, Characteristics, andRisk Factor of Patient with Peripartum Cardiomyopathyin Hasan Sadikin Hospital Bandung

Abstract

Background. Peripartum cardiomyopathy (PPCM) is one of the important health problem and can be fatal. The aim of this study is to determine the prevalence and characteristics of patients with PPCM in the Hasan Sadikin Hospital (RSHS).
Methods. Data were retrieved retrospectively from medical records at the Cardiology and Vascular Medicine, RSHS, Bandung, from 1stJanuary2011 to 31thDecember, 2013. The analysis was performed using SPSS 21 and Chi Square significance test.
Results.Eighty (26.23%,) subjects with PPCM out of 305 women with pregnancy or postpartum and cardiovascular complications are paticipated. The PPCMproportion are significantly decrease by time from 51.25%, 27.5%, 21,25% in 2011, 2012, and 2013 respectively. The average age was 30.3±7.9years. Deliveries were cesarean delivery in 43.8%, pervaginal in 37.5%, forceps in 15%, and vacuum-extractor in 3.8%. Preeclampsia was found in 43.8% of patients and most of them with NYHA functional class IV (86.3The average ejection fraction of 34.8±7.5%.
Conclusion. The prevalence of PPCM in RSHS is 26.23%, with the majority (86.3%) was NYHA functional class IV.Significant risk factorsof PPCM were age over 30 years, multiparous, low socioeconomic, and preeclampsia.

Downloads

Download data is not yet available.

References

Sliwa K,Hilfiker-Kleiner D,Petrie MC,Mebazaa A,Pieske B,Buchmann E,et al.Current State of knowledge on aetiology,diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Sliwa K,Hilfiker-Kleiner D,Petrie MC,Mebazaa A,Pieske B,Buchmann E,et al.Current State of knowledge on aetiology,diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.Eur Heart.2010;12:767-78

Sarker HN, Dass BP. Peripartum cardiomyopathy. ORION. 2009;32:686-89.

Rmaraj K,Sorrel VL.Peripartum Cardiomyopathy:Causes, diagnosis,and treatment. Cleve Clin J Med.2009;76(5):289-96.
MishraVN,MishraN,Devanshi.Peripartumcardiomyopathy.JAPI.2013;61:268-73

Aursulesei V,Datcu MD.Peripartum cardiomyopathy: A Systemic Review. Int J Cardiol. 2009;131(2):8-35.

Elkayam U.Clinical characteristics of peripartum cardiomyopathy in the United State. J Am Coll Cardiol. 2011;58(7):659-70.

Zagrosek VR,Lundqvist CB,Borghi C,Cifkova R,Ferreira R,Foidart JM,et al.Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32:3147-97.

Joint National Comitte. The seventh report of the Joint Nationl Committe on prevention, detection, evaluation,treatment of high blood pressure.NIH.2004: 30-52.

Walenta K,Schwarz V,Schirmer SH,Kinderman I,Friedrich EB,Solomayer EF,et al.Circulating microparticles as indicators of peripartum cardiomyopathy.Eur Heart J.2012;33:1469-79.

Elkayam U,Mohammed W,Akhter,Singh H, Khan S, Bitar F,et al.Pregnancy-Associated Cardiomyopathy: Clinical characteristics and a comparison between early dan late presentation.Circulation.2005;111: 2050-55.

Sliwa K,Fett J,Elkayam U.Peripartum cardiomyopathy. Lancet.2006;368: 687-93.

Lim CP,Sim DK.Peripartum cardiomyopathy:experience in an Asian tertiary centre.Singapore Med J.2013;54(1):24-27.

Shah I,Hafizullah M,Shah TS,Faheem M,Rafiullah.Peripartum cardiomyopathy: risk factors,hospital course and prognosis; experiences at Lady Reading Hospital Peshawar.GARJPP. 2012;1(1):1-11.

Johnson-Coyle L,Jensen L,Sobey A.Peripartum cardiomyopathy: Review and practice guidelines.Am J Crit Care Med.2012;21(2):89-97.

Goland S,Modi K,Bitar F,Janmohamed M,Mirocha JM,Czer L.Clinical profile and predictors of complications in peripartum cardiomyopathy.J Card Fail.2009;28(5):1-6.

Sliwa K,Blauwet L,Tibazarwa K,Smedema JP,Becker A,Mc Muray J,et al.Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof of concept Pilot Study.Circulation.2010;121:1465-73.

Habedank D,Kuhnle Y,Elgeti T,Dudenhausen JW,Haverkamp W,Dietz R.Recovery from peripartum cardiomyopathy after treatment with bromocriptine.2008;10:1149-51.

Anderson JL,Horne BD.Birthing the genetics of peripartum cardiomyopathy .Circulation.2010;121:2157-59.

Shafiq M,Khan RA,Khan A,Shah A,Hussain S.Unrecognised peripartum cardiomyopathy will have dire consequences.Anest Pain Int Care.2013;17(2):195-7.

Hasan JA,Qureshi A,Ramejo BB,Kamran A.Peripartum cardiomyopathy characteristics and outcome in a tertiary care hospital.J Park Med Assoc.2010;60:377-80.

Shaikh S,ShaikhSA.Peripartum cardiomyopathy:Its frequency and maternal outcome.BJOG.2010;16(4):590-3.
Published
2016-03-03
Views
Abstract views: 71   
PDF downloads: 2   
How to Cite
Prevalence, Characteristics, andRisk Factor of Patient with Peripartum Cardiomyopathyin Hasan Sadikin Hospital Bandung. (2016). Indonesian Journal of Cardiology, 36(3), 38-44. https://doi.org/10.30701/ijc.v36i3.476
Section
Clinical Research